Clinical trials
Expanded access Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 13 |
| Approved for marketing | 11 |
| Available | 9 |
| Temporarily not available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Boehringer Ingelheim | 3 |
| Eli Lilly and Company | 3 |
| AstraZeneca | 2 |
| Genentech, Inc. | 2 |
| Nuvalent Inc. | 2 |
| AbbVie | 1 |
| Agenus Inc. | 1 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 35 |
| Pancreatic Neoplasms | 7 |
| Lung Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Carcinoma | 3 |
| Melanoma | 3 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.